KR890006232A - 이미다졸-2-티온카르복스아미드를 사용하여 재환류 손상을 감소시키는 방법 - Google Patents
이미다졸-2-티온카르복스아미드를 사용하여 재환류 손상을 감소시키는 방법 Download PDFInfo
- Publication number
- KR890006232A KR890006232A KR1019880013565A KR880013565A KR890006232A KR 890006232 A KR890006232 A KR 890006232A KR 1019880013565 A KR1019880013565 A KR 1019880013565A KR 880013565 A KR880013565 A KR 880013565A KR 890006232 A KR890006232 A KR 890006232A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- methyl group
- hydrogen atom
- alkyl
- methyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (16)
- 환자에게 하기 일반식의 화합물 및 제약적으로 혀용되는 그의 염 치료 유효량을 투여하는 것으로 되는, 재환유 손상을 예방하거나 또는 경갑시키는 방법.식 중, Q 및 T는 각각 독립적으로 2가 산소 또는 황 원자이고, R1은 수소 원자 또는 (C1-C4)알킬기이고, R2는 -NR2, -NH(R3), 또는 -M(R3)(R4)기 [여기에서, R3는(C1-C4)알킬, 2-, 3-, 또는 4-피리디닐, 2- 또는 3-푸라닐, 2- 또는 3-티에닐, 2- 또는 3-피라닐, 또는 페닐기(여기에서, 피닐기 오르토, 메타 또는 파라 위치에(C1-C4)알킬, (C1-C4)알콕시, (C1-C4)알킬티오, (C1-C4)알킬술폰, (C1-C4)알킬술폭시드, 히드록시, 할로, 트리플루오로메틸, 시아노, 카르복시, 카르브(C1-C4)알콕시, (C1-C4)알카노일아미노, 이미다졸릴, 또는 메틸렌 디옥시기에 의해 임의로 치환됨)이고, R14는(C1-C4)알킬기임]이다.
- 제1항에 있어서, T가 2가 산소 원자인 방법.
- 제1 또는 2항중 어느 하나의 항에 있어서, R1이 수소원자 또는 메틸기인 방법.
- 제1 또는 2항중 어느 하나의 항에 있어서, R2가 -NR2기인 방법.
- 제4항에 있어서, R1이 수소원자 또는 메틸기인 방법.
- 제1 또는 2항중 어느 하나의 항에 있어서, R2가 -NHR3기(여기에서, R3는(C1-C4)알킬기 또는 임의로 치환된 페닐기임)인 방법.
- 제6항에 있어서, R1이 수소원자 또는 메틸기인 방법.
- 제1 또는 2항중 어느 하나의 항에 있어서, R2가 -NHR3기(여기에서, R3는(메틸기임)인 방법.
- 제8항에 있어서, R1이 수소원자 또는 메틸기인 방법.
- 제1 또는 2항중 어느 하나의 항에 있어서, R2가 -NHR3기(여기에서, R3는 4-메톡시페닐기임)인방법.
- 제10항에 있어서, R1이 수소원자 또는 메틸기인 방법.
- 제1 또는 2항중 어느 하나의 항에 있어서, R2가 -N(R3)(R4)기(여기에서, R3및 R4는 각각(C1-C4)알킬기임)인 방법
- 제12항에 있어서, R1이 수소원자 또는 메틸기인 방법.
- 제1 또는 2항중 어느 하나의 항에 있어서, R2가 -N(R3-)(R4)기(여기에서, R3및 R4는 각각 메틸기임)인 방법.
- 제14항에 있어서, R1이 수소원자 또는 메틸기인 방법.
- 제1항에 있어서, T가 2가 산소원자이고, R1이 메틸기이고, R2가 -N(R3)(R4)기(여기에서, R3및 R4는 각각 메틸기임)인, 2,3-디히드로-N,N,5-트리메틸-2-티옥소-1H-이미다졸-4-카르복스아미드인 방법.※ 참고사항 : 최초 출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11014387A | 1987-10-19 | 1987-10-19 | |
US110,143 | 1987-10-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR890006232A true KR890006232A (ko) | 1989-06-12 |
Family
ID=22331436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880013565A KR890006232A (ko) | 1987-10-19 | 1988-10-18 | 이미다졸-2-티온카르복스아미드를 사용하여 재환류 손상을 감소시키는 방법 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0312960A3 (ko) |
JP (1) | JPH01146820A (ko) |
KR (1) | KR890006232A (ko) |
AU (1) | AU610939B2 (ko) |
DK (1) | DK580288A (ko) |
PH (1) | PH27192A (ko) |
ZA (1) | ZA887662B (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA881807B (en) * | 1987-03-20 | 1988-09-05 | Merrell Dow Pharmaceuticals Inc. | Method for reducing reperfusion injury with imidazol-2-thiones |
FR2769838B1 (fr) * | 1997-10-16 | 2000-04-07 | Roc Sa | Utilisation de derives d'azole pour la preparation d'une composition dermatologique ou cosmetologique |
TWI702212B (zh) | 2015-02-09 | 2020-08-21 | 德商拜耳作物科學股份有限公司 | 作為除害劑之經取代的2-硫基咪唑基羧醯胺類 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4405628A (en) * | 1981-03-05 | 1983-09-20 | Merrell Dow Pharmaceuticals Inc. | 4-Pyridylimidazolones and method of use |
US4381393A (en) * | 1981-05-04 | 1983-04-26 | Merrell Dow Pharmaceuticals Inc. | 4-Aminomethyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones |
-
1988
- 1988-10-13 ZA ZA887662A patent/ZA887662B/xx unknown
- 1988-10-14 JP JP63257449A patent/JPH01146820A/ja active Pending
- 1988-10-14 AU AU23765/88A patent/AU610939B2/en not_active Ceased
- 1988-10-17 EP EP88117251A patent/EP0312960A3/en not_active Withdrawn
- 1988-10-18 PH PH37693A patent/PH27192A/en unknown
- 1988-10-18 DK DK580288A patent/DK580288A/da not_active Application Discontinuation
- 1988-10-18 KR KR1019880013565A patent/KR890006232A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DK580288A (da) | 1989-04-20 |
AU2376588A (en) | 1989-06-01 |
AU610939B2 (en) | 1991-05-30 |
EP0312960A3 (en) | 1990-06-13 |
ZA887662B (en) | 1989-06-28 |
JPH01146820A (ja) | 1989-06-08 |
PH27192A (en) | 1993-04-16 |
DK580288D0 (da) | 1988-10-18 |
EP0312960A2 (en) | 1989-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR920021556A (ko) | 라파 마이신 이량체 | |
IL176381A0 (en) | Alpha-hydroxy amides as bradykinin antagonists or inverse agonists | |
BR0010366A (pt) | Composto, composição farmacêutica, método de preparar um composto, e, composto para uso em terapia | |
CA2348993A1 (en) | Substituted phenethylsulfones and method of reducing tnf.alpha. levels | |
ES2115163T3 (es) | Procedimiento para inhibir la proliferacion de celulas de musculos lisos y la restinosis. | |
KR930003912A (ko) | 울혈성 심장 마비 치료법 | |
HUP0100870A2 (hu) | Analgetikumokként alkalmazható alfa-amino-amid-származékok | |
KR870003974A (ko) | 비시클로 치환된 페닐아세토니트릴 유도체 | |
DE3865504D1 (de) | 1-phenyl-3-naphthalenyloxy-propanamine. | |
KR950010887A (ko) | 연골 퇴화 억제 방법 | |
SE8503466D0 (sv) | Aminofenolforeningar | |
KR890006232A (ko) | 이미다졸-2-티온카르복스아미드를 사용하여 재환류 손상을 감소시키는 방법 | |
FR2368278A1 (fr) | Nouveaux medicaments antalgiques contenant des triazines 1-2-4 | |
KR890701100A (ko) | 정신분열병용 의약품 | |
KR920014818A (ko) | 항균제 | |
KR910011807A (ko) | 4-벤질-5-페닐-2,4-디히드로-3h-1,2,4-트리아졸-3-온 및 진경제로서의 그 의 용도 | |
KR890700584A (ko) | 헤테로아릴카르복시아미드 유도체 그의 제조방법 및 그것을 함유하는 의약조성물 | |
KR900701262A (ko) | 췌장염 등에 대한 치료제 | |
RU98122110A (ru) | Пиридил- и пиримидил-пиперазины в лечении болезней, вызываемых злоупотреблением лекарственными и/или наркотическими веществами | |
KR880008999A (ko) | 3-아릴-5-알킬티오-4h-1,2,4-트리아졸 | |
KR890003755A (ko) | 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물 | |
KR870006035A (ko) | 신규 항균제 1-티에닐-4-옥소퀴놀린-3-카복실산 화합물의 제법 | |
CA2361390A1 (en) | Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain | |
KR930703013A (ko) | 항당뇨병제로서 유용한 신규한 글루코하이드롤라제 억제제 | |
DE69002852D1 (de) | Thioformamidderivate. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |